These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

Objectives Clinical practice guidelines (CPGs) support the translation of research evidence
into clinical practice. Key health questions in CPGs ensure that recommendations will be …

Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Background: The Royal Australian and New Zealand College of Psychiatrists is coordinating
the development of clinical practice guidelines (CPGs) in psychiatry, funded under the …

Objective: The present guidelines address the pharmacotherapy of schizophrenia in adults
across different stages, phases, and symptom domains. Method: Guidelines were developed …

Abstract The Royal Australian and New Zealand College of Psychiatrists is co-ordinating the
development of clinical practice guidelines (CPGs) in psychiatry, funded under the National …

Abstract BACKGROUND: The Royal Australian and New Zealand College of Psychiatrists is
co-ordinating the development of clinical practice guidelines (CPGs) in psychiatry, funded …

The guideline makes recommendations for the treatment and management of
schizophrenia. It aims to improve access and engagement with treatment and services for …

Abstract The Schizophrenia Patient Outcomes Research Team (PORT) project has played a
significant role in the development and dissemination of evidence-based practices for …